These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Complete and incomplete lower motor neuron facial palsy in post-COVID-19 mucormycosis. Gautam M; Soni M; Bhaisare V; Rawat P; Walia S; Kori N Indian J Ophthalmol; 2022 Apr; 70(4):1365-1370. PubMed ID: 35326056 [TBL] [Abstract][Full Text] [Related]
24. Cerebral Mucormycosis in Context with COVID-19 Infection. Shastri M; Raval DM; Rathod VM J Assoc Physicians India; 2022 Aug; 70(8):11-12. PubMed ID: 36082737 [No Abstract] [Full Text] [Related]
25. Response to: COVID-19-associated mucormycosis and evolving evidence. Sarda R; Swain S; Ray A; Wig N QJM; 2022 Jun; 115(6):422. PubMed ID: 34264346 [No Abstract] [Full Text] [Related]
26. Initial and ongoing challenges with COVID-19-associated mucormycosis. Sikka K; Goel G; Sharma N; Thakar A Indian J Ophthalmol; 2021 Dec; 69(12):3391-3393. PubMed ID: 34826965 [No Abstract] [Full Text] [Related]
28. Post-COVID-19 mucormycosis presenting as chest wall cellulitis with mediastinitis. Arora N; Gudipati A; Kundu R; Prabhakar N; Suri V; Malhotra P; Jain A Lancet Infect Dis; 2021 Nov; 21(11):1611. PubMed ID: 34717815 [No Abstract] [Full Text] [Related]
29. Post COVID-19 Mucormycosis in the Second Wave-Realities, Uncertainties and Myths. Soman R; Sunavala A J Assoc Physicians India; 2021 Jul; 69(7):11-12. PubMed ID: 34431262 [No Abstract] [Full Text] [Related]
37. COVID-19-associated rhino-orbital mucormycosis: a single-centre experience of 10 cases. Arjun R; Felix V; Niyas VKM; Kumar MAS; Krishnan RB; Mohan V; Ansar A; Gautaam S; Lalitha S QJM; 2022 Jan; 114(11):831-834. PubMed ID: 34181023 [No Abstract] [Full Text] [Related]
38. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus. Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273 [TBL] [Abstract][Full Text] [Related]
39. Oral mucormycosis in post-COVID-19 patients: A case series. Ahmed E; Abou-Bakr A; Hussein RR; El-Gawish AA; Ras AE; Ghalwash DM Oral Dis; 2022 Nov; 28 Suppl 2():2591-2592. PubMed ID: 34289206 [No Abstract] [Full Text] [Related]
40. Should statins be considered for the management of mucormycosis in COVID-19? Chatterjee S; Vardhan B; Singh DK; Maitra A; Ojha UK Diabetes Metab Syndr; 2021; 15(4):102162. PubMed ID: 34186353 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]